Data presented by Johnson & Johnson at the 2026 European Lung Cancer Conference
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial ...
Data presented by Johnson & Johnson at the 2026 European Lung Cancer Conference